News Digest / Ticker: HEPA

Ticker: HEPA

04:04pm, Thursday, Aug 14, 2025

Hepion pivots to diagnostics after $9M raise; delisted, impairment and going‑concern risks

HEPION PHARMACEUTICALS, INC. (NASDAQ: HEPA) Snapshot - what's happening inside: management has pivoted from drug development to diagnostics, sold its Rencofilstat patent assets, completed a $9.0M registered offering in Jan‑2025, in‑licensed CE‑marked diagnostics from New Day (May‑9‑2025) and reco...

06:00pm, Monday, May 19, 2025

Hepion Pharmaceuticals Faces Financial Struggles Amid Lack of Revenue and Delisting Risks

Company Overview: Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is a biopharmaceutical company focused on developing therapies for chronic liver diseases. The firm is located in Morristown, New Jersey, and has faced significant challenges in sustaining operations, leading to a substantial accumulat...